Distribution of citrate and citrate infusion rate during donor plasmaphereses
Background: The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐a...
Saved in:
Published in | Journal of clinical apheresis Vol. 31; no. 1; pp. 59 - 62 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.02.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background:
The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation.
Subjects and Methods:
Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time.
Results:
130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated.
Conclusion:
The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. J. Clin. Apheresis 31:59–62, 2016. © 2015 Wiley Periodicals, Inc. |
---|---|
AbstractList | The purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation.BACKGROUNDThe purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation.Data of 32 regular donors of plasma initially collected for a study published in 2010 were re-analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time.SUBJECTS AND METHODSData of 32 regular donors of plasma initially collected for a study published in 2010 were re-analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time.130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated.RESULTS130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated.The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min.CONCLUSIONThe total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. Background: The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re‐analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time. Results: 130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated. Conclusion: The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. J. Clin. Apheresis 31:59–62, 2016. © 2015 Wiley Periodicals, Inc. The purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Data of 32 regular donors of plasma initially collected for a study published in 2010 were re-analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time. 130 ± 12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated. The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. Background: The purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing plasma donation. Subjects and Methods: Data of 32 regular donors of plasma initially collected for a study published in 2010 were re-analyzed to determine the amount of citrate received by the donor and the citrate infusion rate (CIR) in mg/kg/min to the donor. Donor plasmaphereses (DP) were performed with the automated Haemonetics plasma collecting system 2 (PCS2). Plasma volume was programmed at 760 ml including AC. CIR was calculated from citrate received by the donors divided by the body weight over time. Results: 130±12 ml TSC was used for 760 ml plasma. An average of 110 ml TSC or 84.6% of citrate load was in collected plasma and not given to the donor. From the difference of 20 ml or 514 mg citrate an average CIR of 0.16 mg/kg/min was calculated. Conclusion: The total amount of citrate received by the donor is minimal and the average CIR is below the critical level of 1 mg/kg/min. J. Clin. Apheresis 31:59-62, 2016. © 2015 Wiley Periodicals, Inc. |
Author | Taborski, Uwe Evers, Josef |
Author_xml | – sequence: 1 givenname: Josef surname: Evers fullname: Evers, Josef email: dr_evers@hotmail.com organization: Octapharma Plasma, Plasmazentrum Aachen, Aachen, Germany – sequence: 2 givenname: Uwe surname: Taborski fullname: Taborski, Uwe organization: Octapharma Plasma, Plasmazentrum Aachen, Aachen, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26011445$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtL7DAYhoMoOo4u_ANScKOL6pdL03Ypc7ziDVEENyFtE83YSeYkLeq_N-PoLARdJSHP-5E87zpats4qhLYw7GMAcjCu5T7BDOgSGmAoixRjwMtoADmlKWFZuYbWQxgDQFnSbBWtEQ4YM5YN0OU_Ezpvqr4zziZOJ7XpvOxUIm2z2Bur-zC7_zw1vTf2KWmcdT6ZtjJM5PRZeRVU2EArWrZBbX6tQ3R_fHQ3Ok0vrk_ORocXac0Io6kEXeO6hgZrYKxRrOBNTghrcp5zQnWleFVlQLmSlSRMU0ZKruNHKC-KSjI6RLvzuVPv_vcqdGJiQq3aVlrl-iBwzqHgFIoZuvMDHbve2_i6SGUcKJTR0hBtf1F9NVGNmHozkf5dfIuKwN4cqL0LwSu9QDCIWQkiliA-S4jswQ82ipQzwVGnaf9KvJpWvf8-WpyPDr8T6TwR61Nvi4T0L4LnNM_Ew9WJeLw5ZfSG3gpOPwA1M6Vs |
CitedBy_id | crossref_primary_10_1016_j_bonr_2018_100188 crossref_primary_10_1111_vox_13512 crossref_primary_10_1016_j_transci_2017_04_001 crossref_primary_10_5301_ijao_5000589 crossref_primary_10_1002_jca_21626 crossref_primary_10_1111_trf_15244 crossref_primary_10_1111_trf_13907 crossref_primary_10_1136_bmjopen_2024_085786 crossref_primary_10_1002_jca_22025 crossref_primary_10_35754_0234_5730_2024_69_2_153_162 |
Cites_doi | 10.1046/j.1537-2995.1999.39111266.x 10.1046/j.1537-2995.2001.41091165.x 10.1159/000317092 10.1002/jca.21222 10.1016/j.bone.2009.11.008 10.1002/1098-1101(2000)15:4<230::AID-JCA3>3.0.CO;2-B 10.1159/000357991 |
ContentType | Journal Article |
Copyright | 2015 Wiley Periodicals, Inc. 2016 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2015 Wiley Periodicals, Inc. – notice: 2016 Wiley Periodicals, Inc. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1002/jca.21403 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1098-1101 |
EndPage | 62 |
ExternalDocumentID | 3919214091 26011445 10_1002_jca_21403 JCA21403 ark_67375_WNG_ZPH43P3R_6 |
Genre | shortCommunication Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XV2 ZGI ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c4243-a0fc1cc0d1f044de486d7224d767623fbe6bb5036eaba24f34296f2453688ba43 |
IEDL.DBID | DR2 |
ISSN | 0733-2459 1098-1101 |
IngestDate | Fri Jul 11 01:38:51 EDT 2025 Sun Jul 13 04:14:18 EDT 2025 Thu Apr 03 06:56:42 EDT 2025 Tue Jul 01 03:59:24 EDT 2025 Thu Apr 24 23:06:05 EDT 2025 Wed Jan 22 16:25:35 EST 2025 Wed Oct 30 09:50:00 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | citrate infusion rate citrate citrate toxicity plasmapheresis apheresis |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2015 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4243-a0fc1cc0d1f044de486d7224d767623fbe6bb5036eaba24f34296f2453688ba43 |
Notes | ArticleID:JCA21403 ark:/67375/WNG-ZPH43P3R-6 istex:B38C518CEE8509A451C86FF25846391DDC81795B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 26011445 |
PQID | 1756030973 |
PQPubID | 1006360 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1760863084 proquest_journals_1756030973 pubmed_primary_26011445 crossref_primary_10_1002_jca_21403 crossref_citationtrail_10_1002_jca_21403 wiley_primary_10_1002_jca_21403_JCA21403 istex_primary_ark_67375_WNG_ZPH43P3R_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2016 |
PublicationDateYYYYMMDD | 2016-02-01 |
PublicationDate_xml | – month: 02 year: 2016 text: February 2016 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Worcester |
PublicationTitle | Journal of clinical apheresis |
PublicationTitleAlternate | J. Clin. Apheresis |
PublicationYear | 2016 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher 2012;27:117-125. Amrein K, Katschnig C, Sipurzynski S, Stojakovic T, Lanzer G, Stach E, Pieber TR, Dobnik H. Apheresis affects bone and mineral metabolism. Bone 2010;46:789-795. Evers J, Betz J, Blankenburg T, Engelen T, Hansen M, Laitinen T, Taborski U. Influence of NaCl 0.9% infusion during plasmaphereses on IgG content in plasma. Transfus Med Hemother 2010;37:191-194. Bolan CD, Greer SE, Cecco SA, Oblitas JM, Rehak NN, Leitmann SF. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001;41:1166-1171. Schlenke P, Frohn C, Steinhardt MM, Kirchner H, Klüter H. Clinically relevant hypokalemia, and loss of hemoglobin and platelets during stem cell apheresis. J Clin Apher 2000;15:230-235. Beeck H, Becker T, Kiessig ST, Kaeser R, Wolter K, Hellstern P. The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study. Transfusion 1999;39:1266-1270. Diekamp U, Gneißl J, Rabe A, Kiessig ST. Donor hemovigilance during preparatory plasmapheresis. Transfus Med Hemother 2014;41:123-133. 2015 2010; 37 2012; 27 2010; 46 2014; 41 2000; 15 2010 1999; 39 2001; 41 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_10_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_2_1 |
References_xml | – reference: Beeck H, Becker T, Kiessig ST, Kaeser R, Wolter K, Hellstern P. The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study. Transfusion 1999;39:1266-1270. – reference: Schlenke P, Frohn C, Steinhardt MM, Kirchner H, Klüter H. Clinically relevant hypokalemia, and loss of hemoglobin and platelets during stem cell apheresis. J Clin Apher 2000;15:230-235. – reference: Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher 2012;27:117-125. – reference: Diekamp U, Gneißl J, Rabe A, Kiessig ST. Donor hemovigilance during preparatory plasmapheresis. Transfus Med Hemother 2014;41:123-133. – reference: Amrein K, Katschnig C, Sipurzynski S, Stojakovic T, Lanzer G, Stach E, Pieber TR, Dobnik H. Apheresis affects bone and mineral metabolism. Bone 2010;46:789-795. – reference: Bolan CD, Greer SE, Cecco SA, Oblitas JM, Rehak NN, Leitmann SF. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001;41:1166-1171. – reference: Evers J, Betz J, Blankenburg T, Engelen T, Hansen M, Laitinen T, Taborski U. Influence of NaCl 0.9% infusion during plasmaphereses on IgG content in plasma. Transfus Med Hemother 2010;37:191-194. – volume: 39 start-page: 1266 year: 1999 end-page: 1270 article-title: The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study publication-title: Transfusion – volume: 27 start-page: 117 year: 2012 end-page: 125 article-title: Anticoagulation techniques in apheresis: from heparin to citrate and beyond publication-title: J Clin Apher – volume: 41 start-page: 1166 year: 2001 end-page: 1171 article-title: Comprehensive analysis of citrate effects during plateletpheresis in normal donors publication-title: Transfusion – volume: 37 start-page: 191 year: 2010 end-page: 194 article-title: Influence of NaCl 0.9% infusion during plasmaphereses on IgG content in plasma publication-title: Transfus Med Hemother – volume: 15 start-page: 230 year: 2000 end-page: 235 article-title: Clinically relevant hypokalemia, and loss of hemoglobin and platelets during stem cell apheresis publication-title: J Clin Apher – volume: 41 start-page: 123 year: 2014 end-page: 133 article-title: Donor hemovigilance during preparatory plasmapheresis publication-title: Transfus Med Hemother – volume: 46 start-page: 789 year: 2010 end-page: 795 article-title: Apheresis affects bone and mineral metabolism publication-title: Bone – year: 2015 – year: 2010 – ident: e_1_2_6_3_1 – ident: e_1_2_6_7_1 doi: 10.1046/j.1537-2995.1999.39111266.x – ident: e_1_2_6_10_1 doi: 10.1046/j.1537-2995.2001.41091165.x – ident: e_1_2_6_6_1 – ident: e_1_2_6_5_1 doi: 10.1159/000317092 – ident: e_1_2_6_4_1 – ident: e_1_2_6_9_1 doi: 10.1002/jca.21222 – ident: e_1_2_6_2_1 doi: 10.1016/j.bone.2009.11.008 – ident: e_1_2_6_8_1 doi: 10.1002/1098-1101(2000)15:4<230::AID-JCA3>3.0.CO;2-B – ident: e_1_2_6_11_1 doi: 10.1159/000357991 |
SSID | ssj0009935 |
Score | 2.1038043 |
Snippet | Background:
The purpose of this study was to describe the distribution of trisodium‐citrate 4% (TSC) anticoagulant (AC) between the product and the donors... The purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors undergoing... Background: The purpose of this study was to describe the distribution of trisodium-citrate 4% (TSC) anticoagulant (AC) between the product and the donors... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 59 |
SubjectTerms | Adolescent Adult Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - blood apheresis Blood Donors citrate citrate infusion rate citrate toxicity Citrates - administration & dosage Citrates - adverse effects Citrates - blood Cross-Over Studies Female Humans Immunoglobulin G - blood Infusions, Intravenous Male Middle Aged plasmapheresis Plasmapheresis - adverse effects Plasmapheresis - methods Prospective Studies Young Adult |
Title | Distribution of citrate and citrate infusion rate during donor plasmaphereses |
URI | https://api.istex.fr/ark:/67375/WNG-ZPH43P3R-6/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjca.21403 https://www.ncbi.nlm.nih.gov/pubmed/26011445 https://www.proquest.com/docview/1756030973 https://www.proquest.com/docview/1760863084 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS91AEB7EQvGlrdXW06qkItKXaLK72eTgk3jpQTgiolRKYdlboLVN5Fyg-Oud2VxEsVD6lpBJsreZ-XZ39huA7cRlTrPEx1qyMhYyLeMh8zy2zufcWJH6hM47j8_k6EqcXmfXC7DfnYVp-CH6BTfSjGCvScG1me49kIb-xBk_I7Y5tL8Uq0WA6OKBOgr9bghfzClXmciGHatQwvb6Nx_5ohfUrH-eA5qPcWtwPCev4XtX5Cbe5GZ3PjO79u4Jm-N_1ukNvGoBaXTQjKBlWPDVW3g5brfcV2B8RNS6bVasqC4j-yMQ2ka6cv01DtM5LbtF4a45-hi5uqon0S3C89-ayAv81E9X4erk-PJwFLc5GGIrmOCxTkqbWpu4tEyEcF4U0uXo9l0u0Yzy0nhpTIZu0GujmSg5-jdZYoNzWRRGC_4OFqu68msQoeVwBB9Sz4YIA6UuUu2H0jttC-ZyM4DPXW8o2xKUU56MX6qhVmYKm0eF5hnAVi9627ByPCe0E7q0l9CTGwpjyzP19eyL-nY-EvycXyg5gPWuz1WrwVOFsErS9lOO3_nUP0bdow0VXfl6TjISZ4Q8KcQA3jdjpf8ZUbXhZDXDWoUe_3s51enhQbj48O-iH2EJkVsbPr4Oi7PJ3G8gOpqZzaAG9w8vCGs |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5qC-qL97ZHq0YR8SVtsrvZ5IAvpVqPtedQSotFkGVvAXtJyrmA-Oud2VxKpYL4lpBJsruzs_Pt7uw3AG8SlznNEh9rycpYyLSMh8zz2Dqfc2NF6hM67zyeyNGx2DvJTpbgfXcWpuGH6BfcyDLCeE0GTgvSW1esoac45WdEN3cLViijd5hQHV6RR6HnDQGMOWUrE9mw4xVK2Fb_6jVvtEIN-_MmqHkduQbXs3sfvneFbiJOzjYXc7Npf_3B5_i_tXoA91pMGm03neghLPnqEdwet7vuj2H8gdh128RYUV1G9kfgtI105fpr7KkLWnmLwl1z-jFydVVPo0tE6Bea-Av8zM-ewPHux6OdUdymYYitYILHOiltam3i0jIRwnlRSJej53e5xJGUl8ZLYzL0hF4bzUTJ0cXJElucy6IwWvBVWK7qyq9DhIOHIwSRejZEJCh1kWo_lN5pWzCXmwG869ShbMtRTqkyzlXDrswUNo8KzTOA173oZUPMcZPQ26DTXkJPzyiSLc_U18kn9e1gJPgBP1RyABud0lVrxDOFyErSDlSO33nVP0bzoz0VXfl6QTISJ4U8KcQA1prO0v-M2NpwvpphrYLK_15OtbezHS6e_rvoS7gzOhrvq_3Pky_P4C4CuTaafAOW59OFf45gaW5eBJv4DY84DIY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9qC8UvWt-nbY0i4pe0m93NJkc_lZ7nWb3jKBZLEZbNPqCtJsc9QPzrnd08SqWC-C0hk2R3Z2bnt6_fALwhJjWKEhsrQV3MReLiPrUs1sZmrNA8scSfdx5PxOiUH5-lZ2tw0J6Fqfkhugk37xmhv_YOPjNu_5o09BJH_NSzzd2BDS5I7k16cHLNHYWBN-xfzHyyMp72W1ohQve7V28Eow3frj9vQ5o3gWuIPMP78K0tc73h5GpvtSz29K8_6Bz_s1JbcK9BpNFhbUIPYM2WD2Fz3Ky5P4LxwHPrNmmxospF-iIw2kaqNN012unKz7tF4a4--xiZqqzm0Qzx-Q_l2Qvswi4ew-nw_ZejUdwkYYg1p5zFijidaE1M4gjnxvJcmAzjvskE9qPMFVYURYpx0KpCUe4YBjjhsMGZyPNCcfYE1suqtM8gwq7DePyQWNpHHChUnijbF9YonVOTFT1412pD6oah3CfK-C5rbmUqsXlkaJ4evO5EZzUtx21Cb4NKOwk1v_L72LJUfp18kOfTEWdTdiJFD7ZbncvGhRcScZXw608ZfudV9xidz6-oqNJWKy-DhicYyXkPnta20v3Mc7XhaDXFWgWN_72c8vjoMFw8_3fRl7A5HQzl54-TTy_gLqK4Ziv5Nqwv5yu7g0hpWewGj_gNej0LPg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+citrate+and+citrate+infusion+rate+during+donor+plasmaphereses&rft.jtitle=Journal+of+clinical+apheresis&rft.au=Evers%2C+Josef&rft.au=Taborski%2C+Uwe&rft.date=2016-02-01&rft.eissn=1098-1101&rft.volume=31&rft.issue=1&rft.spage=59&rft_id=info:doi/10.1002%2Fjca.21403&rft_id=info%3Apmid%2F26011445&rft.externalDocID=26011445 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0733-2459&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0733-2459&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0733-2459&client=summon |